Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Contraception|September 1, 1988
Patterns of bleeding and body iron stores during the use of a levonorgestrel-releasing intracervical deviceK Ratsula, J Toivonen, H AllonenThe Journal of International Medical Research|January 1, 1982
Bioavailability of paediatric mixtures containing phenoxymethylpenicillin calcium or potassium saltK Soininen, H Allonen, J PostiClinical Pharmacology and Therapeutics|November 1, 1981
Midazolam kineticsH Allonen, G Ziegler, U KlotzAdvances in Contraception : the Official Journal of the Society for the Advancement of Contraception|March 1, 1986
A randomized comparative trial of Nova-T and TCu200Ag in YugoslaviaM Kozuh, L Andolsĕk, H AllonenObstetrics and Gynecology|February 1, 1991
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devicesJ Toivonen, T Luukkainen, H AllonenAnnals of Clinical Research|October 1, 1979
Erythromycin levels in serum during treatment with erythromycin stearate and baseH Saarni, J Kanto, H AllonenInternational Journal of Clinical Pharmacology and Biopharmacy|February 1, 1979
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazineA Lehtonen, H Allonen, T KleimolaInternational Journal of Clinical Pharmacology and Biopharmacy|June 1, 1979
Alpha- and beta-adrenoceptor blocking properties of labetalol in renin releaseR Lammintausta, M Koulu, H AllonenActa Chirurgica Hungarica|January 1, 1988
Clinical experience with intrauterine contraceptive devices (IUDs) inserted with and without tailI Batár, L G Lampé, H AllonenInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1981
Pharmacokinetics of labetalol in healthy volunteersJ Kanto, H Allonen, T Kleimola, et al.Pageof 7